Penn State Finds New Path to Treat 30% of Cancers

Scientists discovered that a DNA repair protein gone overactive damages cells just like BRCA mutations, potentially allowing thousands more cancer patients to access gentler, targeted treatments.

The finding could expand personalized cancer care to patients who previously had limited options.